Correlation Between Gossamer Bio and Nuvectis Pharma
Can any of the company-specific risk be diversified away by investing in both Gossamer Bio and Nuvectis Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Gossamer Bio and Nuvectis Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Gossamer Bio and Nuvectis Pharma, you can compare the effects of market volatilities on Gossamer Bio and Nuvectis Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Gossamer Bio with a short position of Nuvectis Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Gossamer Bio and Nuvectis Pharma.
Diversification Opportunities for Gossamer Bio and Nuvectis Pharma
0.32 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Gossamer and Nuvectis is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding Gossamer Bio and Nuvectis Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nuvectis Pharma and Gossamer Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Gossamer Bio are associated (or correlated) with Nuvectis Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nuvectis Pharma has no effect on the direction of Gossamer Bio i.e., Gossamer Bio and Nuvectis Pharma go up and down completely randomly.
Pair Corralation between Gossamer Bio and Nuvectis Pharma
Given the investment horizon of 90 days Gossamer Bio is expected to generate 1.49 times less return on investment than Nuvectis Pharma. But when comparing it to its historical volatility, Gossamer Bio is 1.54 times less risky than Nuvectis Pharma. It trades about 0.04 of its potential returns per unit of risk. Nuvectis Pharma is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 680.00 in Nuvectis Pharma on November 2, 2024 and sell it today you would lose (6.00) from holding Nuvectis Pharma or give up 0.88% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Gossamer Bio vs. Nuvectis Pharma
Performance |
| Timeline |
| Gossamer Bio |
| Nuvectis Pharma |
Gossamer Bio and Nuvectis Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Gossamer Bio and Nuvectis Pharma
The main advantage of trading using opposite Gossamer Bio and Nuvectis Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Gossamer Bio position performs unexpectedly, Nuvectis Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nuvectis Pharma will offset losses from the drop in Nuvectis Pharma's long position.| Gossamer Bio vs. Biomea Fusion | Gossamer Bio vs. Stoke Therapeutics | Gossamer Bio vs. Akero Therapeutics | Gossamer Bio vs. Replimune Group |
| Nuvectis Pharma vs. Replimune Group | Nuvectis Pharma vs. Lyra Therapeutics | Nuvectis Pharma vs. Kronos Bio | Nuvectis Pharma vs. Gossamer Bio |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |